Skip to main content
Log in

17β-Estradiol increases the receptor number and modulates the action of 1,25-dihydroxyvitamin D3 in human osteosarcoma-derived osteoblast-like cells

  • Laboratory Investigations
  • Published:
Calcified Tissue International Aims and scope Submit manuscript

Abstract

It is well known that 17β-estradiol (E2) and 1,25-dihydroxyvitamin D3 (1,25(OH)2D3) have important roles in bone metabolism. This study was undertaken to examine E2 regulation of 1,25(OH)2D3 receptor (VDR) expression and the biological action of 1,25(OH)2D3 in human osteoblast-like cells. When human osteosarcoma-derived osteoblast-like cells were treated with varying concentrations of E2, the VDR levels increased by up to 100% in a dose-dependent manner. VDR levels significantly increased at 10 nM E2 and this increase plateaued at 100 nM E2. E2-dependent increase of VDR was time dependent, plateauing, at 24 hours and was maintained for at least 48 hours in human osteoblast-like cells. Scatchard analysis showed that E2 increased the number of VDR (12.3±0.4 versus 26.5±0.3 fmol/mg protein; mean ±SE of three independent experiments) rather than the Kd (0.15±0.02 versus 0.16±0.01 nM; mean±SE of three independent experiments). Tamoxifen (50 nM), a specific competitor with E2, completely abolished the E2-induced increase of VDR. The levels of VDR mRNA (4.5 kb) from the cells increased in a dose-dependent manner after E2 treatment. With regard to the biological effects, E2 increased by 10–25% the inhibitory effect of 1,25(OH)2D3 on cell growth. However, E2 did not increase the stimulation of alkaline phosphatase activity by 1,25(OH)2D3. The present study suggests that E2 modulates the biological action of 1,25(OH)2D3 through VDR levels in bone cells.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Lindsay R (1988) Sex steroids in the pathogenesis and prevention of osteoporosis. In: Liggs BL, Melton LJ III (eds) Osteoporosis etiology, diagnosis, and management. Raven Press, New York, p 333

    Google Scholar 

  2. Beato M (1989) Gene regulation by steroid hormones. Cell 56: 335–344

    Google Scholar 

  3. Komm BS, Terpening CM, Benz DJ, Graeme KA, Gallegos A, Kore M, Green GL, O'Malley BW, Haussler MR (1988) Estrogen binding, receptor mRNA, and biological responses in osteoblast-like osteosarcoma cells. Science 241:81–83

    Google Scholar 

  4. Eriksen EF Colvard DS, Berg NJ, Graham ML, Mann KG, Spelsberg TC, Riggs BL (1988) Evidence of estrogen receptors in normal human osteoblast-like cells. Science 241:84–86

    Google Scholar 

  5. Pensler JM, Rodosevich JA, Higbee R, Langman CB (1990) Osteoclast isolated from membranous bone in children exhibit nuclear estrogen receptors. J Bone Mineral Res 5:797–802

    Google Scholar 

  6. Ishibe M, Ishibe Y, Ishibashi T, Nojima T, Rosier RN, Puzas JE, Kaneda K (1994) Low content of estrogen receptors in human giant cell tumors of bone. Arch Orthop Trauma Surg 113: 106–109

    Google Scholar 

  7. Wronski TJ, Cintron M, Doherty AL, Dann LM (1988) Estrogen treatment prevents osteopenia and depresses bone turnover in ovariectomized rats. Endocrinology 123:681–686

    Google Scholar 

  8. Takano-Yamamoto T, Rodan GA (1990) Direct effects of 17β-estradiol on trabecular bone in ovariectomized rats. Proc Natl Acad Sci USA 87:2172–2176

    Google Scholar 

  9. Gray TK, Flynn TC, Gray KM, Nabell LM (1987) 17β-estradiol acts directly on the clonal osteoblastic cell line UMR 106. Proc Natl Acad Sci USA 84:6267–6271

    Google Scholar 

  10. Ernst M, Schmid C, Froesch ER (1988) Enhanced osteoblast proliferation and collagen gene expression by estradiol. Proc Natl Acad Sci USA 85:2307–2310

    Google Scholar 

  11. Ernst M, Heath JK, Rodan GA (1989) Estradiol effects on proliferation, messenger ribonucleic acid for collagen and insulin-like growth factor-I, and parathyroid hormone-stimulated adenylate cyclase activity in osteoblastic cells from calvariae and long bones. Endocrinology 125:825–833

    Google Scholar 

  12. Gray TK (1989) Estrogens and the skeleton; cellular and molecular mechanisms. J Steroid Biochem 34:285–287

    Google Scholar 

  13. Peck WA, Woods W (1988) The cells of bone. In: Riggs BL, Melton LJ III (eds), Osteoporosis etiology, diagnosis, and management, Raven Press, New York, p 1

    Google Scholar 

  14. Coccia PF, Krivit W, Cervenka J, Clawson C, Kersey JH, T.H.K., Nesbit ME, Ramsay NKC, Warkentin PI, Teitelbaum SL, Kahn AJ, Brown DM (1980) Successful bone marrow transplantation for infantile malignant osteoporosis. N Engl J Med 302: 701–708

    Google Scholar 

  15. Dokoh S, Donaldson CA, Haussler MR (1984) Influence of 1,25-dihydroxyvitamin D3 on cultured osteogenic sarcoma cells: correlation with 1,25-dihydroxyvitamin D3 receptors. Cancer Res 44:2103–2109

    Google Scholar 

  16. Franceschi RT, James WN, Zerlauth G (1985) 1α-25-dihydroxyvitamin D3 specific regulation of growth, morphology, and fibronectin in a human osteosarcoma, cell line. J Cell Physiol 123:401–409

    Google Scholar 

  17. Gallagher JC Goldgar D (1990) Treatment of postmenopausal osteoporosis with high doses of synthetic calcitriol. Ann Intern Med 113:649–655

    Google Scholar 

  18. Somjen D, Kaye AM, Harell A, Weisman Y (1989) Modulation by vitamin D of rat bone to gonadal steroids status, of the responsiveness. Endocrinology 125:1870–1876

    Google Scholar 

  19. Liel Y, Kraus S, Levy J, Shany S (1992) Evidence that estrogens modulate activity and increase the number of 1,25-dihydroxyvitamin D receptors in osteoblas-like cells (ROS 17/2.8). Endocrinology 130:2597–2601

    Google Scholar 

  20. Walters MR (1981) An estrogen-stimulated 1,25-dihydroxyvitamin D3 receptor in rat uterus. Biochem Biophys Res Commun 103:721–726

    Google Scholar 

  21. Levy J, Zuili I, Yankowitz N, Shany S (1984) Induction of cytosolic receptors for 1α,25 dihydroxyvitamin, D3 in the immature rat uterus by oestradiol. J Endocrinology 100:265

    Google Scholar 

  22. Duncan WE, Glass AR, Wray HL (1991) Estrogen regulation of the nuclear 1,25-dihydroxyvitamin D3 receptor in rat liver and kidney. Endocrinology 129:2318–2324

    Google Scholar 

  23. Escaleira MTF, Sonohara S, Brentani MM (1993) Sex steroids induced up-regulation of 1,25-(OH)2 vitamin, D3 receptors in T 47D breast cancer cells. J Steroid Biochem Mol Biol 45:257–263

    Google Scholar 

  24. Mahonen A, Pirskanen A, Pirskanen A Maenpaa PH (1991) Homologous and heterologous regulation of 1,25-dihydroxyvitamin D-3 receptor mRNA levels in human osteosarcoma cells. Biochim Biophys Acta, 1088:111–118

    Google Scholar 

  25. Sasaki T, Yagi T, Usui M, Matsuyama T, Nojima T (1986) Biological, functional and morphological characteristics, of human bone and soft tissue tumors in nude, mice. Hokkaido J Med Sci 61:257–270

    Google Scholar 

  26. Chen TL, Feldman D (1981) Regulation of 1,25-dihydroxyvitamin D3 receptors in cultured mouse bone cells. J Biol Chem 256:5561–5566

    Google Scholar 

  27. Nanes MS, Rubin J, Titus L, Hendy GN, Catherwood BD (1990) Interferon gamma inhibits the synthesis bone gla protein by a pretranslational mechanism. Endocrinology 127:588–594

    Google Scholar 

  28. Lowry OH (1955) Micromethods for the assay of enzyme. II: specific procedures. Alkaline phosphatase. Methods Enzymol 4:371–372

    Google Scholar 

  29. Bradford MM (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72:248–254

    Google Scholar 

  30. Chen TL, Cone CM, Morey-Holton E, Feldman D (1982), Glucocorticoid regulation of 1,25(OH)2-vitamin D3 receptors in cultured mouse bone cells. J Biol Chem 257:13564–13569

    Google Scholar 

  31. Chen TL, Cone CM, Morey-Holton E, Feldman D (1983) 1α,25-dihydroxyvitamin D3, receptors in cultured rat osteoblast-like cells. J Biol Chem 258:4350–4355

    Google Scholar 

  32. Chen TL, Haushka PV, Feldman D (1986) Dexamethasone increases 1,25-dihydroxyvitamin D3 receptor levels and augments bioresponses in rat osteoblast-like cells. Endocrinology 118: 1119–1126

    Google Scholar 

  33. Somjen D, Weisman Y, Harell A, Berger E, Kaye AM (1989) Direct and sex-specific stimulation by sex steroids of creatine kinase and DNA synthesis. Proc Natl Acad Sci USA 86:3361–3365

    Google Scholar 

  34. Keeting EK, Scott RE, Colvard DS, Han IK, Spelberg TC, Riggs BL (1991) Lack of direct effect of estrogen on proliferation and differentiation of normal human osteoblast-like cells. J Bone Miner Res 6:297–304

    Google Scholar 

  35. Canalis E (1983) Effect of hormones and growth factors on alkaline phosphatase activity and collagen synthesis in cultured rat calvariae. Metabolism 32:14–20

    Google Scholar 

  36. Ramp WK, Baker RL (1985) 1,25-Dihydroxyvitamin D3 decreases alkaline phosphatase activity in cultures of embryonic chick tibiae (42029) Proc Soc Exp Biol Med 178:437–442

    Google Scholar 

  37. Majeska RJ, Rodan GA (1982) The effect of 1,25-(OH)2-D3 on alkaline phosphatase activity in osteoblasts by osteosarcoma cell lines. J Biol Chem 257:3362–3365

    Google Scholar 

  38. Manolagas SC, Spiess YH, Burton DW, Deftos LJ, (1983) Mechanism of action of 1,25-dihydroxyvitamin D3-induced stimulation of alkaline phosphatase in cultured osteoblast-like cells. Mol Cell Endocrinol 333:27–36

    Google Scholar 

  39. Kumegawa M, Ikeda E, Tanaka S, Haneji T, Yora T, Sakagishi Y, Minami N, Hiramatsu M (1984) The effects of prostaglandin E2, parathyroid hormone, 1,25 dihydroxycholecalciferol, and cyclic nucleotide analogs on alkaline phosphatase activity in osteoblastic cells. Calcif Tissue Int, 36:72–76

    Google Scholar 

  40. Fritsch J, Grosse B, Lieberherr M, Balsan S (1985) 1,25-Dihydroxyvitamin D3 is required for growth-independent expression of alkaline phosphatase in cultured rat osteoblasts. Calcif Tissue Int 37:639–645

    Google Scholar 

  41. Pritchard JA, MacDonald PC, Gant NF (1985) Williams obstetrics. Appleton-Century-Crofts, Norwalk, CT

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Ishibe, M., Nojima, T., Ishibashi, T. et al. 17β-Estradiol increases the receptor number and modulates the action of 1,25-dihydroxyvitamin D3 in human osteosarcoma-derived osteoblast-like cells. Calcif Tissue Int 57, 430–435 (1995). https://doi.org/10.1007/BF00301946

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00301946

Key words

Navigation